Renovo Ltd. Announces The Appointment Of Dr. Carl Peck To Its Scientific And Clinical Advisory Board
10/19/2005 5:08:45 PM
Renovo today announced the appointment of Dr Carl Peck to its Scientific and Clinical Advisory Board. Professor of Pharmacology at the Georgetown University Medical Center, Dr Peck is the Chairman and Founder of NDA Partners LLC, the Founder and Director of Georgetown University Center for Drug Development Science (CDDS), a former Director of the FDA’s Center for Drug Evaluation and Research (CDER) and Assistant Surgeon General of the United States.
Dr Peck was Director of the US FDA’s Center for Drug Evaluation and Research from 1987 – 1993, where he was praised for having brought to the FDA “the spirit of innovative scientific management”. He founded the Georgetown University CDDS, where he has researched drug development issues and taught since 1994. Important methodologies, championed by CDDS include PBPK modelling, simulation of clinical trials, and the theory of scientific drug development that optimises causal and empirical information to enable efficient transition of promising agents to useful therapeutic drugs. Dr Peck led and contributed to many innovations at the FDA, including the Subpart E and accelerated approval regulations, employment of surrogate endpoints, and efficient dossier review procedures. In 2000, Dr Peck was awarded the FDA Distinguished Alumnus Award and in 2002 an Honorary Doctorate degree by Uppsala University for “Outstanding Contributions to the Science of Drug Development”.